The NCCC consists of 23 voting members, which includes 11 Regular Government Employees (federal members) and 12 Special Government Employees (non-federal members).
The 11 Regular Government Employees (RGEs) are composed of individuals designated by the heads of the following federal agencies: The Centers for Medicare & Medicaid Services (CMS), the Agency for Healthcare Research and Quality (AHRQ), the Centers for Disease Control and Prevention (CDC), the Indian Health Service (IHS), the Department of Veterans Affairs (VA), the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the Health Resources and Services Administration (HRSA), the Department of Defense (DoD), the Department of Agriculture (USDA), and the Office of Minority Health (OMH) at the Office of the Assistant Secretary for Health (OASH).
The 12 Special Government Employees (SGEs) are appointed by the Secretary and have expertise in prevention, care, and epidemiology of complex metabolic or autoimmune diseases that result from insulin-related issues and represent a significant disease burden in the United States, including complications due to such diseases.
William Herman, MD, MPH
Director, Michigan Center for Diabetes Translational Research
University of Michigan
Ann Arbor, Michigan
Dr. Herman is Professor of Internal Medicine and Epidemiology at the University of Michigan and Director of the Michigan Center for Diabetes Translational Research. As a practicing endocrinologist, his clinical interests focus on the prevention and treatment of diabetes, its complications, and comorbidities. His research focuses on the broad areas of clinical trials, epidemiology, health services research, and clinical economics. From 2015 to 2017, he co-chaired the American Diabetes Association’s Professional Practice Committee. For several years, he has also chaired the National Committee for Quality Assurance (NCQA) Workgroup on Diabetes Quality Measures.
Regular Government Employees
Ann Albright, PhD, RDN
Division Director, Division of Diabetes Translation
Centers for Disease Control and Prevention
Dr. Ann Albright, Director of the Division of Diabetes Translation leads a team who strive to eliminate the preventable burden of diabetes through leadership, research, programs, and policies that translate science into practice. Prior to commencing her post at CDC, Dr. Albright served as Chief of the California Diabetes Program for the California Department of Health Services. During this time, Dr. Albright also held an academic appointment in the Institute for Health and Aging at University of California, San Francisco. Dr. Albright served as the Senior Health Policy Advisor in the Office of the United States Surgeon General and led the Secretary of Health’s Diabetes Detection Initiative. She is published in areas of exercise, nutrition, diabetes complications, diabetes surveillance, and public health approaches to diabetes prevention and management.
Ann Bullock, MD
Director, Division of Diabetes Treatment and Prevention
Office of Clinical and Preventive Services
Indian Health Service
Dr. Bullock is the Director of the Division of Diabetes Treatment and Prevention (DDTP) within the Indian Health Service. DDTP’s responsibilities include: (1) overseeing the programmatic aspects of the Special Diabetes Program for Indians, a $150 million per year congressionally-mandated grant program providing resources to over 300 Indian health sites in 35 states; (2) providing estimates of diabetes prevalence in American Indians/Alaska Natives; (3) conducting an annual assessment of over 40 diabetes clinical process, education, and outcome elements in patients with diabetes across the Indian health system; and (4) providing diabetes training, clinical practice recommendations, clinical tools, and culturally-relevant patient education materials to Indian health clinicians. Dr. Bullock is an enrolled member of the Minnesota Chippewa Tribe.
William Chong, MD
Acting Deputy Director, Division of Metabolism and Endocrinology Products
Office of New Drugs, Center for Drug Evaluation and Research
Food and Drug Administration
Dr. Chong is the Acting Deputy Director of the Division of Metabolism and Endocrinology Products at the Food and Drug Administration (FDA). He earned his medical degree from Temple University and completed his Internal Medicine training at Thomas Jefferson University Hospital in Philadelphia, PA. Dr. Chong went on to complete his fellowship in Endocrinology and Metabolism at the National Institutes of Health before joining the FDA in 2012. During his time at the FDA, Dr. Chong has worked primarily with drug products that alter glucose metabolism.
Paul Conlin, MD
Chief, Medical Service
Veterans Affairs Boston Healthcare System
Dr. Conlin is Chief, Medical Service at VA Boston Healthcare System, Professor of Medicine at Harvard Medical School and Maurice Strauss Chair at Boston University School of Medicine. He is also Director of the Clinical and Translational Research Academy in Harvard Catalyst - The Harvard Clinical and Translational Science Center. Dr. Conlin has been a practicing endocrinologist at VA Boston since 1989 and is Chair, VA Diabetes-Endocrinology Field Advisory Committee. His research focuses on improving patient-centered care for individuals with diabetes mellitus using information technology and health services approaches.
Naomi Fukagawa, MD, PhD
Director, Beltsville Human Nutrition Research Center
United States Department of Agriculture
Dr. Fukagawa is the Director, USDA Beltsville Human Nutrition Research Center, and previously Professor of Medicine and Acting Director Gerontology, University of Vermont. She is a board-certified pediatrician with expertise in nutritional biochemistry/metabolism, including protein and energy metabolism and the role of diet in aging and chronic diseases, such as diabetes mellitus. She was Vice-Chair of the 2010 USDA/HHS Dietary Guidelines Advisory Committee. She received her MD degree from Northwestern University and her PhD from the Massachusetts Institute of Technology. Her clinical training included residency at the Children’s Hospital of Philadelphia, University of Pennsylvania, Chief Residency at the University of Vermont, and nutrition/ gerontology fellowships at the Children’s Hospital and Beth Israel Hospital, Harvard Medical School.
Barbara Linder, MD, PhD
Senior Advisor, Childhood Diabetes Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Dr. Linder is Senior Advisor for Childhood Diabetes Research at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. Dr. Linder administers a portfolio of research grants related to the care of individuals with type 1 diabetes and youth with type 2 diabetes. She oversees many of NIDDK’s large clinical consortia, including the TODAY, DPPOS, GRADE and RISE studies, and the SEARCH study which is co-led by the CDC and NIDDK. She also works at the NIH Pediatric Endocrine Clinic. Prior to coming to the NIH, Dr. Linder was on the faculty at the Albert Einstein College of Medicine, where she directed the Pediatric Endocrinology Fellowship. She received her M.D., Ph.D. from Columbia University’s College of Physicians and Surgeons.
Aaron Lopata, MD
Chief Medical Officer, Maternal and Child Health Bureau
Office of the Associate Administrator
Health Resources and Services AdministrationDr. Lopata joined HRSA as the Maternal and Child Health Bureau’s (MCHB) Chief Medical Officer in November 2014. Dr. Lopata came to MCHB from the Office of Management and Budget (OMB) where he worked for 10 years overseeing HRSA’s MCH Bureau, the HIV/AIDS Bureau, and the Office of Rural Health. In his role as Chief Medical Officer at MCHB Dr. Lopata has worked to highlight the critical role played by HRSA/MCHB programs in promoting the health and well-being of women and children. Specifically, Dr. Lopata has worked to promote MCHB’s Home Visiting, Healthy Start, and interventions that utilize community-based 2-generation approaches to ensure that at-risk children, mothers, and families have access to critical services they require to thrive. Dr. Lopata continues practice medicine part-time with Capitol Area Pediatrics in Vienna, VA., where he sees patients Saturday mornings once or twice a month.
Barry Marx, MD
Director, Office of Clinician Engagement
Center for Clinical Standards and Quality
Centers for Medicare & Medicaid Services
Dr. Marx currently serves as the Director of the Office of Clinician Engagement for the Centers for Medicare and Medicaid Services (CMS), and Medical Officer in the Center for Clinical Standards and Quality.
Dr. Marx comes to CMS from the Department of Defense, most recently as the Chief of Primary Care of the Kirk US Army Health Clinic at Aberdeen Proving Ground. Prior to working for the Department of Defense, Dr. Marx was the Senior Medical Advisor to the Office of Head Start. Dr. Marx has worked in Federally Qualified Health Centers for more than two decades.
Donald Shell, MD, MA
Director, Disease Prevention
Disease Management and Population Health Policy & Oversight
Office of the Assistant Secretary of Defense for Health Affairs
Department of DefenseDr. Donald Shell graduated from the Howard University College of Medicine and completed a General Surgery internship, a residency in Community Health and Family Medicine, and fellowship training in Primary Care Sports Medicine and Adult Fitness at Marshall University. Dr. Shell then served as a team physician for The Ohio State University, USOC Training Center, USA Track & Field, USA Basketball; an Olympic Games medical officer, and USOC Doping Control Crew Chief. Prior to coming to the department of Defense, Dr. Shell has also served as a local Public Health Officer, a state public health program director and has practiced primary care sports medicine and family medicine in private and university-based environments.
Howard Tracer, MD
Medical Officer, U.S. Preventive Services Task Force Program
Center for Evidence and Practice Improvement
Agency for Healthcare Research and Quality
Dr. Tracer is a Medical Officer with the U.S. Preventive Services Task Force program at AHRQ. Prior to joining AHRQ, he was chief of the Mid-Atlantic Permanente Medical group’s (MAPMG) Endocrinology service for fifteen years. During that time, he was also MAPMG’s physician partner to Kaiser’s Care Management Institute (CMI) for Diabetes and Bone Health programs. Dr. Tracer’s work with CMI included creating evidence based clinical guidelines, screening recommendations, treatment algorithms, disease specific population registries, and monitoring and improving disease-related quality of care measures. Dr. Tracer is a graduate of Princeton University and the New York University School of Medicine. He completed his training in Internal Medicine at NYU-Bellevue Hospital Center, and his fellowship in Endocrinology and Metabolism at the National Institutes of Health.
CAPT Samuel Wu, Pharm D.
Public Health Advisor, Office of Minority Health
CAPT Samuel Wu currently serves as the public health advisor in the Office of Minority Health and as the health policy lead for the Asian American, Native Hawaiian, and Pacific Islander population. In addition, he is the Designated Federal Officer for the Advisory Committee on Minority Health. CAPT Wu’s past assignments included Senior Program Management Officer at the Food and Drug Administration’s Office of the Chief Information Officer and Public Health Advisor at the Health Resources and Services Administration’s Office of Health Equity. Prior to joining the government, CAPT Wu worked as a consultant pharmacist where he provided drug therapy management services to nursing home residents. As a member of the Public Health Service Commissioned Corps, he has been serving on a disaster response team for over 10 years and has deployed to multiple humanitarian missions. CAPT Wu also enjoys volunteer work. He has volunteered for a non-profit organization providing medical services in Latin American and in India. Currently, he volunteers at the Pan Asian Volunteer Health Clinic in Gaithersburg, Maryland. CAPT Wu earned his doctor of Pharmacy degree from University of Maryland Baltimore School of Pharmacy.
Special Government Employees
Shari Bolen, MD, MPH
Associate Division Director of Internal Medicine
The MetroHealth System
Dr. Bolen is an Associate Professor of Medicine at Case Western Reserve University (CWRU) and Associate Division Director of Internal Medicine at The MetroHealth System (MHS). Dr. Bolen serves as the Director of Cardiovascular Disease Programs for Better Health Partnership – a regional health improvement collaborative; co-leads the Ohio Cardiovascular Health Collaborative funded by the Ohio Department of Medicaid; and co-leads the Population Health Sciences unit at the Center for Health Care Research and Policy for CWRU. She has served on the NIDDK pragmatic trial study section and serves on the MHS Social Determinants of Health and Environmental Sustainability Advisory Boards. Her career has focused on evidence synthesis and implementation of evidence-based strategies and innovative programs to improve cardiovascular health outcomes with specific interest in diabetes, obesity, and hypertension. Her primary goal is to improve the care of the patients and communities she serves.
John Boltri, MD, FAAFP
Chair and Professor, Department of Family and Community Medicine
Northeast Ohio Medical University College of Medicine
Dr. Boltri graduated from Ohio State University (1987) and Summa Family Medicine Residency (1990) and has been practicing and teaching for 28 years. He joined Northeast Ohio Medical University in 2014 as chairman of the Department of Family and Community Medicine and founding medical director of NEOMED’s student run free clinic.
Dr. Boltri is fellow of the American Academy of Family Physicians and AAFP liaison to the National Diabetes Education Program Coordinating Committee strategic directions group. He served as principle investigator on three major projects: an NIH funded 5-year Diabetes Prevention project, a Medicaid community health worker grant to improve health of underserved communities and a HRSA grant to enhance primary care training focused on rural and underserved areas in Ohio.
J. William (Bill) Cook, MD
Chair, Board of Directors
Ascension Medical Group
Dr. Cook is from Catonsville, MD. He attended Loyola College, University of MD Medical School, and trained at the York Hospital (PA) in Internal Medicine, where he was Chief Resident. He has been with Ascension St Agnes Hospital since 1993, practicing inpatient and outpatient primary care in addition to teaching residents and students. He has served on numerous committees in various roles, currently President of the Medical Staff and Chair of the Board of Directors for the Ascension Medical Group, Baltimore. He also serves as Medical Director for AMG-Baltimore for the University of MD Quality Care Network. He still lives in Catonsville with his wife, Elizabeth.
Ayotunde Dokun, MD, PhD, FACE
Associate Professor of Medicine and Endocrinology
Director, Division of Endocrinology and Metabolism
Carver School of Medicine
University of Iowa, IA
Dr. Dokun is an Associate Professor of Medicine and Endocrinology and Director of the Division of Endocrinology and Metabolism at the Carver School of Medicine, University of Iowa, IA. He is a graduate of the Medical Scientist Training Program (MSTP) at the Mt Sinai Graduate School of Biological Sciences and the Mt Sinai School of Medicine (now Icahn School of Medicine), New York, NY where he earned his MD and PhD. He completed residency training in Internal Medicine and Fellowship in Endocrinology at Duke University Medical Center, Durham, NC. He is a Fellow of the American College of Endocrinology (FACE) and an alumnus of the prestigious Robert Wood Johnson Foundation (RWJF), Amos Medical Faculty Development Program (AMFDP). He currently runs a translational research laboratory that studies the molecular
Jasmine Gonzalvo, PharmD, BCPS, BC-ADM, CDE, LDE
Clinical Associate Professor
Purdue University College of Pharmacy
Dr. Gonzalvo is a Clinical Associate Professor in the College of Pharmacy at Purdue University. She provides Cardiovascular Risk Reduction services in a population with serious mental illness (SMI) and for those who primarily speak Spanish at Eskenazi Health in Indianapolis, IN. Her publications relate to cardiovascular risk reduction in individuals with SMI and diabetes education in the pharmacy setting. She served on the Board of Directors for the American Association of Diabetes Educators (AADE) from 2015-2017. She currently serves on the Board of Directors for the National Certification Board for Diabetes Educators. She is active in diabetes-related advocacy efforts at the State and Federal levels. She has been recognized with several teaching and mentorship awards throughout her career.
M. Carol Greenle, MD, FACP, FACE
Center for Medicare and Medicaid Innovation (CMMI) Transforming Clinical Practice Initiative (TCPi)
Grand Junction, Colorado
Dr. Greenlee FACP, FACE is board certified in Internal Medicine and in Endocrinology, Diabetes and Metabolism with over 30 years’ experience in private practice endocrinology. In 2016 she received the Endocrine Society Laureate Award for Outstanding Clinical Practitioner. She is devoted to improving the delivery of health care, patient-centered care and collaboration across the medical neighborhood. She co-chaired the American College of Physicians (ACP) Medical Neighbor workgroup and was a lead author of the ACP position paper “The Patient-Centered Medical Home Neighbor”. She chaired the ACP workgroup on the High Value Care Coordination toolkit and the Pediatric-to- Adult-Care Transitions initiative and currently chairs the ACP Council of Subspecialty Societies (CSS) with a seat on the ACP Board of Regents. She currently serves as one of the Nation Faculty co-chairs for the Transforming Clinical Practice initiative (TCPi).
Meredith Hawkins, MD, MS
Director, Global Diabetes Institute
Albert Einstein College of Medicine
Bronx, New York
Dr. Hawkins is a Professor of Medicine in the Diabetes Research and Training Center at the Albert Einstein College of Medicine. She earned her M.D. degree cum laude from the University of Toronto and a Master of Science in Clinical Research Methods cum laude from the Albert Einstein College of Medicine. Dr. Hawkins is founder and director of Einstein's Global Diabetes Institute, which aims to build strategic partnerships in research and education to combat the burgeoning global diabetes epidemic. In partnership with researchers abroad she is investigating the pathogenesis of the poorly-understood entity of 'malnutrition diabetes'. Dr. Hawkins is currently researching the mechanisms and pathophysiology of diabetes mellitus and is practicing among the diverse patient population of the Bronx.
Shannon Idzik, DNP, ANP-BC, FAAN, FAANP
Associate Dean and Professor, Doctor of Nursing Practice Program
University of Maryland Baltimore School of Nursing
Dr. Idzik is an Associate Professor and Associate Dean of the Doctor of Nursing Practice program at University of Maryland School of Nursing. She has been on faculty there since 2005 and previously served as the program director for the Adult Gero NP program. She has worked clinically as a nurse practitioner in endocrinology, bariatric surgery, primary care where she managed large panels of patients with diabetes. She currently maintains a faculty practice as a nurse practitioner in the University of Maryland Comprehensive Care Center. She was awarded AANP State Award for Excellence in 2012, was selected as a Fellow of the American Academy of Nurse Practitioners in 2014 and a Fellow of the American Academy of Nursing in 2017.
Chair, Juvenile Diabetes Research Foundation (JDRF) International Board of Directors
Ms. Leake serves as Chair of the JDRF International Board of Directors. JDRF is the leading global organization funding type 1 diabetes (T1D) research. She is a volunteer, joined the Board in 2008 and was named Vice Chair in 2016. During her board service she has worked in numerous roles: chairing Development (fundraising), Lay Review (research grants) and Information Technology committees. Continuing her type 1 diabetes affiliations, she served as a member of the National Institutes of Health NIDDK Advisory Council 2014-18 and has been nominated to serve on the National Clinical Care Commission. Her connection to type 1 diabetes is her daughter who was diagnosed at age 10.Ms. Leake received a BA in economics from the University of Mississippi and an MBA from Tulane University. She currently leads a family timber and land development business in Mississippi. Prior to that she was an executive with IBM.
Dean Schillinger, MD
Chief, UCSF Division of General Internal Medicine
San Francisco General Hospital
San Francisco, California
Dr. Schillinger is a UCSF Professor of Medicine in Residence and serves as Chief of the UCSF Division of General Internal Medicine at San Francisco General Hospital (SFGH). He is a practicing general internist at SFGH, a large urban public hospital, and is an internationally recognized expert in health communication science. In 2006, he founded the UCSF Center for Vulnerable Populations and currently directs the UCSF Health Communications Research Program at the Center. From 2008-13, Dr. Schillinger also served as Chief Medical Officer for the Diabetes Prevention and Control Program for California. Author of over 250 peer-reviewed articles, he has focused his research on health communication for vulnerable populations, carrying out a number of studies exploring the impact of limited health literacy on prevention and control of diabetes and heart disease. In 2013, he received the Everett M Rogers Award from APHA in recognition of his lifelong contributions to advancing the study and practice of public health communication. In 2016, Dr. Schillinger was honored with a James L Irvine California Leadership Award for his innovative work in to improve public health literacy and address the epidemic of Type 2 diabetes in youth and young adults. He currently serves as UCSF PI for an NIDDK Center for Type 2 Diabetes Translational Research and an NIDDK R01 to evaluate the population-level effects of policy initiatives to reduce the burden of diabetes.
David Strogatz, PhD, MSPH
Director, Center for Rural Community Health
Bassett Research Institute, Bassett Health Care Network
Cooperstown, New York
Dr. Strogatz received a BA in sociology from Amherst College and a PhD in chronic disease epidemiology from the University of North Carolina. He has served on the faculty of Schools of Public Health of the University of North Carolina and the University at Albany, State University of New York. In 2011 he began his current position as Director of a new research center (the Center for Rural Community Health) within the Bassett Healthcare Network, which serves the population of eight counties in upstate New York. Dr. Strogatz’s experience in developing and evaluating clinical and public health programs and interventions includes projects addressing the diagnosis and management of chronic conditions and community-based efforts to increase physical activity and healthy diet.
Designated Federal Officer
Clydette Powell, MD, MPH, FAAP
Medical Officer, Office on Women's Health
Office of the Assistant Secretary for Health
U.S. Department of Health and Human Services
Dr. Powell served as the Designated Federal Officer for the National Clinical Care Commission from April 2018 until August 2019 and resumed this role in October 2020. She has worked with the National Clinical Care Commission since its inauguration in October 2018. From September 2015 until October 2020, she worked at the Office of Disease Prevention and Health Promotion, in Rockville, MD, initially as the Director of the Division of Health Care Quality, and most recently in the Division of Prevention Science. Her responsibilities have included oversight of the federal efforts to advance two National Action Plans: one for the prevention of Health Care Associated Infections and the other for prevention of Adverse Drug Events. Prior to her work at HHS, Dr Powell served as Medical Officer, US Agency for International Development, Washington, DC, for 15 years in global public health. The Johns Hopkins University School of Medicine awarded her medical degree, and her MPH is from UCLA School of Public Health. Her residencies and fellowship training were at the University of Pittsburgh Medical Centers. She is triple board certified in pediatrics, child neurology, and preventive medicine/public health. She continues to practice clinical medicine part-time, most recently at a federally qualified health center for the underserved.